This article will address Canbisol, a topic of great relevance and relevance in contemporary society. Canbisol has aroused great interest in different areas, whether in politics, culture, science or everyday life. In this sense, the aim is to analyze and discuss the different aspects related to Canbisol, offering a broad and diverse vision that allows us to understand its importance and impact today. Through the detailed analysis of Canbisol, we seek to generate an enriching and reflective debate that contributes to the understanding and evolution of this important topic.
| Clinical data | |
|---|---|
| Drug class | Cannabinoid |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H38O3 |
| Molar mass | 374.565 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Canbisol (Nabidrox) is a synthetic cannabinoid derivative that is the dimethylheptyl homologue of 9-nor-9β-hydroxyhexahydrocannabinol (HHC). It is a potent agonist at both the CB1 and CB2 receptors, with a binding affinity of 0.1 nM at CB1 and 0.2 nM at CB2.[1] It is mainly used in scientific research, in receptor binding studies to determine the structure and function of the cannabinoid receptors,[2][3][4] but has been made illegal in some countries due to its possible abuse potential as a cannabinomimetic drug.[5]